Market Trends of Italy Wound Care Management Industry
The Pressure Ulcer Segment is Expected to Witness a Major Share During the Forecast Period
Pressure ulcers are wounds on the skin and underlying tissue primarily caused by persistent pressure on the skin. Although they can affect anyone, they typically afflict those who are bedridden or spend a lot of time in a chair or wheelchair. Also, older adults (70 years and above) and obese people are most likely to get affected by pressure ulcers.
Factors such as the growing geriatric population, the increasing burden of chronic diseases, and serious injuries requiring long-term bed rest are expected to drive the growth of the pressure ulcer segment of the Italian wound care management market during the forecast period.
The growing burden of the geriatric population in the country is expected to contribute to the market segment's growth. For instance, according to the Eurostat database updated in June 2023, nearly 24% of the Italian population in 2023 were 65 years and above. The database also reported that in 2022, 7.6% of the Italian population was aged 80 years and above. Since older adults commonly have lower mobility and spend a lot of time sitting and resting, they are at an increased risk of pressure ulcers. With such a high geriatric population in the country, the target population for pressure ulcer care products is expected to increase, which may contribute to the growth of the segment.
The Wound Care Devices Segment is Expected to Hold the Fastest Growth Rate During the Forecast Period
Wound care devices include therapy devices based on negative pressure therapy, pressure relief devices, compression therapy, and hyperbaric oxygen equipment. Factors such as the growing burden of targeted diseases and increasing research studies in the area of wound care devices are propelling the growth of the market segment during the forecast period.
For instance, an article from Scientific Reports in February 2023 states that the prevalence of diabetes amounts to 6.4% in Italy owing to sedentary lifestyles, overweight, and obesity.
The centralized regulatory authority's approval of products also propels the market segment's growth. For instance, in April 2021, Biocomposites received the European CE mark's approval to use STIMULAN in infected bone and soft tissue. The STIMULAN Rapid Cure device and STIMULAN Kit can carry an antibiotic directly into the bone and soft tissues. Thus, owing to the above-mentioned factors, the wound care devices segment is expected to project significant growth during the forecast period.
